Cocrystal Pharma (COCP) Stock: Buy, Sell, or Hold?
COCP - Cocrystal Pharma, Inc. Common Stock
$0.95
0.04 (4.17%)
▲
5d:
-6.86%
30d:
-17.39%
90d:
+3.41%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 13, 2026
17d
Get Alerted When COCP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: COCP shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: COCP shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: COCP is currently trading at $0.95, which is considered oversold relative to its 30-day fair value range of $1.00 to $1.18.
Technical Outlook: Technically, COCP is in a uptrend. Immediate support is located at $0.91, while resistance sits at $1.11. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.00 (+742.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, COCP is in a uptrend. Immediate support is located at $0.91, while resistance sits at $1.11. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.00 (+742.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.00 -
$1.18
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (48/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.2%)
- BULLISH: Trading 742.1% below Wall St target ($8.00)
- WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.00 -
$1.18
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.91
Resistance Level
$1.11
Current Trend
Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.00
Wall Street Target
$8.00
(+742.1%)
Revenue Growth (YoY)
26.9%
Share & Embed Analysis
Last updated: October 26, 2026 2:18 AM ET
Data refreshes hourly during market hours. Next update: 3:18 AM
Data refreshes hourly during market hours. Next update: 3:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is COCP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$92 | 73 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
23 analysts |
$108 | 58 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$130 | 69 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 56 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$280 | 43 HOLD |
